Compare NRXP & CSPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRXP | CSPI |
|---|---|---|
| Founded | 2015 | 1968 |
| Country | United States | United States |
| Employees | 29 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.2M | 85.6M |
| IPO Year | N/A | 1994 |
| Metric | NRXP | CSPI |
|---|---|---|
| Price | $3.73 | $8.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $38.25 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 27.6K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 1.15% |
| EPS Growth | N/A | ★ 75.00 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $58,730,000.00 |
| Revenue This Year | $2,547.84 | N/A |
| Revenue Next Year | $1,591.73 | N/A |
| P/E Ratio | ★ N/A | $219.00 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $1.65 | $7.55 |
| 52 Week High | $5.06 | $15.00 |
| Indicator | NRXP | CSPI |
|---|---|---|
| Relative Strength Index (RSI) | 48.47 | 40.26 |
| Support Level | $3.45 | $7.98 |
| Resistance Level | $3.84 | $9.31 |
| Average True Range (ATR) | 0.32 | 0.69 |
| MACD | -0.09 | -0.04 |
| Stochastic Oscillator | 45.00 | 19.14 |
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.